Date(s) - Wednesday, June 13th, 2018
5:30 PM - 7:30 PM
What makes a talk about science, technology, engineering and math (STEM) even more entertaining? Why, beer of course!
Join our monthly STEM Tavern that features a fascinating science presentation plus good beer. For each beer sold at STEM Tavern, Soaring Ridge Craft Brewers will make a donation to the Science Museum of Western Virginia! A food truck will also be on hand.
If you are interested in more information about the STEM Tavern programming, you can contact Sarah Van Zele at email@example.com or 540.342.5718.
Join us on the 2nd Wednesday of each month at 5:30 pm at Soaring Ridge Craft Brewers (523 Shenandoah Ave.). Talks begin at 6:00 pm!
June 13: Ryan King “The transition from bloodletting to IV-fluid therapy to …”
Imagine going to the doctor with a headache; when you walk into the clinic the doctor immediately says “Hah! I’ve seen this one before. Nothing we won’t be able to fix with a little bloodletting.” Odds are most people would assume their doctor was crazy and look elsewhere. For much of human history however, bloodletting was one of the most common and ubiquitously prescribed treatments for the majority of illnesses. In the mid-19th century, a select few scientists began to apply medical statistics to “modern” treatments of the time and quickly came to realize that putting fluids into the body, not removing them, actually proved beneficial to disease. Jump forward one and a half centuries to present day and you will find IV-therapy, not bloodletting, is the first line treatment of choice for most conditions. With hindsight being 20/20, it is easy to look at our ancestors and negatively judge the seemingly barbaric practice of unconditional bloodletting. Looking forward is much more difficult, but one could hypothesize our descendants will look at us with equal contempt when reading histories of physicians in the 21st century prescribing IV-therapy unconditionally. As the world of biomedical research makes a push toward individualized medicine, it is important that advances in IV-therapy not fall below the research radar.
Ryan King is a PhD student currently studying at the Virginia Tech Carilion Research Institute (VTCRI). Before moving to Roanoke, I completed my bachelor’s degree in biology at the University of North Carolina at Chapel Hill where I also became passionate about research surrounding cardiovascular disease. When I am not in the lab, I love talking about science with anyone and everyone that will listen. I am particularly passionate about engaging the community around me in the science being done in their own neighborhood. When I am not conducting science, talking about science, or reading about science, I enjoy playing guitar, hiking and trying to play golf.